🇺🇸 FDA
Pipeline program

Influenza vaccine

TraNsgripe1-2

Phase 3 mab completed

Quick answer

Influenza vaccine for Infection in Solid Organ Transplant Recipients is a Phase 3 program (mab) at Design Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Infection in Solid Organ Transplant Recipients
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials